$DERM
Journey Medical Corporation Common Stock
XNAS
Why is DERM up today? It is at $6.47 (+1.17%), and our scanner flagged it 3 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment DERM spikes, and full due diligence on DERM — key stats, earnings, dilution and insider activity. Free.
Get free $DERM alerts the moment volume spikes
Our scanner flagged $DERM 3 times in the last 30 days. Create a free account to track $DERM, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $6.47
- Change today
- +1.17%
- Previous close
- $6.40
- 52-week range
- $4.31 – $9.55
- Market cap
- $74M
- Shares outstanding
- 11.6M
- Institutional own.
- 61.96%
- Total held
- 76.4%
- Tradeable float
- 2.7M 24% of shares · after 14% insiders + 62% institutions
- Short interest
- 3.1M ▲ +2% vs prior · as of 2026-07-15
- Days to cover
- 19.0d
- Avg daily volume
- 201K
- Next earnings
- Aug 12 · in 6d (after close)
- Exchange
- XNAS
- 5m
- 0.7x
- 15m
- 0.5x
- 1h
- 0.4x
- 1D
- 0.0x
Get free DERM + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $DERM up today?
Here is the latest on DERM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DERM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystShareholder Vote, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying8 buys, 0 sells last 3 months (11/1 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Herskowitz Neil Director | Acquired (grant/award) | +50K 0.4% of company | added 42% | 169K | n/a | Jul 1, 26 |
Smith Justin Adam Director | Acquired (grant/award) | +50K 0.4% of company | added 28% | 232K | n/a | Jul 1, 26 |
Toledano Miranda Jayne Director | Acquired (grant/award) | +50K 0.4% of company | added 42% | 169K | n/a | Jul 1, 26 |
Rosenwald Lindsay A Md Director | Acquired (grant/award) | +10K 0.09% of company | added 4.7% | 221K | n/a | Jun 25, 26 |
Pearce Michael Cooper Director | Acquired (grant/award) | +10K 0.09% of company | added 17% | 67K | n/a | Jun 25, 26 |
Herskowitz Neil Director | Acquired (grant/award) | +10K 0.09% of company | added 9.2% | 119K | n/a | Jun 25, 26 |
Smith Justin Adam Director | Acquired (grant/award) | +10K 0.09% of company | added 5.8% | 182K | n/a | Jun 25, 26 |
Toledano Miranda Jayne Director | Acquired (grant/award) | +10K 0.09% of company | added 9.2% | 119K | n/a | Jun 25, 26 |
Maraoui Claude Officer | Acquired (grant/award) | +49K 0.4% of company | added 2.1% | 2.44M | n/a | Apr 22, 26 |
Benesch Joseph Officer | Acquired (grant/award) | +29K 0.3% of company | added 12% | 261K | n/a | Apr 22, 26 |
Alloush Ramsey Officer | Acquired (grant/award) | +47K 0.4% of company | added 8.5% | 599K | n/a | Apr 22, 26 |
Maraoui Claude Officer | Sold (automatic/other) | -11K 0.09% of company | sold 0.5% | 2.39M | $81K at $7.47 | Aug 25, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfAt-the-market (ATM) offering active — the company can keep selling new shares into the market over time (ongoing). If $DERM runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- At-the-market (ATM) program — sells new shares into the market gradually over time
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$DERM Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$DERM Activity
News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.
DERM stock FAQ
Why is $DERM up today?
Here is the latest on DERM from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for DERM today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the DERM stock price today?
DERM last traded at $6.47, up 1.17% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
When does DERM report earnings?
Journey Medical Corporation Common Stock (DERM) is next expected to report earnings on Wednesday, August 12, 2026 (after close), about 6 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Where can I see live DERM alerts?
The DERM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged DERM 3 times in the last 30 days.
What exchange is DERM on?
DERM (Journey Medical Corporation Common Stock) trades on XNAS, with a market cap of about $74M.
Is DERM good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge DERM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.